Acne Inversa
11
0
0
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
9.1%
1 terminated out of 11 trials
88.9%
+2.3% vs benchmark
0%
0 trials in Phase 3/4
63%
5 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 8 completed trials
Clinical Trials (11)
Anifrolumab for Hidradenitis Suppurativa
To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa
A Pilot Study to Explore the Role of Gut Flora in Acne
Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA)
A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa
A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa
Wound Etiology and Healing Study
Molecular Characteristics of Brodalumab in Hidradenitis Suppurativa
Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa
Microwave Ablation in Mild Axillary Hidradenitis Suppurativa
Intense Pulsed Light Therapy for Hidrosadenitis Suppurativa